Multiple Strikes Achieve Remarkable Tumor-Inhibition Efficiency via Multi-mechanism Combination
Author:
Affiliation:
1. School of Pharmaceutical Science, Zhengzhou University, Zhengzhou 450001, China
2. Collaborative Innovation Center of Drug Research and Safety Evaluation, Zhengzhou 450001, Henan Province, China
Funder
National Natural Science Foundation of China
Henan Province
Publisher
American Chemical Society (ACS)
Subject
Biomedical Engineering,Biomaterials
Link
https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.2c00778
Reference35 articles.
1. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers
2. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
3. Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer
4. Accelerating Cancer Therapy Development: The Importance of Combination Strategies and Collaboration. Summary of an Institute of Medicine Workshop
5. Combinational strategy for high-performance cancer chemotherapy
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanotherapeutics targeting autophagy regulation for improved cancer therapy;Acta Pharmaceutica Sinica B;2024-06
2. GSH/HAase/pH Triple-responsive Nanotheranostic Agent for Synergistic Therapy Guided by Tumor-targeting Fluorescence/Photoacoustic Dual-mode Imaging;Acta Chimica Sinica;2024
3. The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity;Cell Death Discovery;2023-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3